As shown in Table 1, the extent of Tiam1 overexpression in prostate carcinoma was statistically significantly associated with the presence of LVI (P=0.031), GS ⩾7 (P=0.044) and with disease recurrence (P=0.016), but not with any other parameter. The gene discussed is TIAM1; the disease is prostate carcinoma.